Citation Impact

Citing Papers

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Point-of-Care Testing
2012 Standout
Clinical advantages of using mini-bypass systems in terms of blood product use, postoperative bleeding and air entrainment: an in vivo clinical perspective☆
2007
Aspirin failure in patients presenting with acute cerebrovascular ischaemia
2011
High rate of unprovoked recurrent venous thrombosis is associated with high thrombin‐generating potential in a prospective cohort study
2008
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality
2010
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up
2012 StandoutNobel
Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria
2007
The blood bank: from provider to partner in treatment of massively bleeding patients
2007
Platelets and acute cerebral infarction
2012 StandoutNobel
Exercise Standards for Testing and Training
2013 Standout
Contact activation: important to consider when measuring the contribution of tissue factor‐bearing microparticles to thrombin generation using phospholipid‐containing reagents
2014 StandoutNobel
Hyperprolactinemia in Patients on Antipsychotic Drugs Causes ADP-Stimulated Platelet Activation That Might Explain the Increased Risk for Venous Thromboembolism: Pilot Study
2003
Effects of prolactin on platelet activation and blood clotting
2013 StandoutNobel
Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram
2009
Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease
2018
Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients
2008 Standout
Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management
2017
Minimally Invasive Closed Circuit Versus Standard Extracorporeal Circulation for Aortic Valve Replacement
2007
The Effect of Fibrinogen Substitution on Reversal of Dilutional Coagulopathy: An In Vitro Model
2006
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
2009 StandoutNobel
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions
2015
Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method
2012
Exercise training enhances endogenous fibrinolysis in peripheral arterial disease
2004
Thrombin generation assays: accruing clinical relevance
2004
Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial
2013
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Systemic Lupus Erythematosus
2011 Standout
Thrombin During Cardiopulmonary Bypass
2006
Cost reduction of perioperative coagulation management in cardiac surgery: value of ‘bedside’ thrombelastography (ROTEM)☆
2007
Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit
2017
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
The adhesion molecule P-selectin and cardiovascular disease
2003
Minimized closed circuit/centrifugal pump extracorporeal circulation: an effective aid in coronary bypass operations in Jehovah's Witnesses
2006
Macroprolactinemia, like hyperprolactinemia, may promote platelet activation
2010
Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH
2017
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
How much warfarin is enough in APS related thrombosis?
2004
Adipose Tissue as an Endocrine Organ
2004 Standout
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy
2012
Identifying non‐responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition
2010
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Risk of Postoperative Hemorrhage after Intracranial Surgery after Early Nadroparin Administration: Results of a Prospective Study
2003
How I use fibrinogen replacement therapy in acquired bleeding
2014
Prolactin does not affect human platelet aggregation or secretion
2009
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development
2007 StandoutNobel
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Serum prolactin and macroprolactin in heart failure: no relation to established laboratory or clinical parameters
2010
Thrombin generation and venous thromboembolism
2008
Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and Hemodilution
2010
Thrombin generation, a function test of the haemostaticthrombotic system
2006
Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed?
2009
The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.
2013
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Leptin and Cardiovascular Disease
2008
Perioperative Coagulation Management and Control of Platelet Transfusion by Point-of-Care Platelet Function Analysis
2007
Guidelines for the management of hemophilia
2012 Standout

Works of A. Siegemund being referenced

Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study
2007
Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating
2003
Enhanced platelet activation by prolactin in patients with ischemic stroke
2006
Differences in Platelet Activation by Prolactin and Leptin
2004
Prolactin Receptor Signaling during Platelet Activation
2003
Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures
2000
Aspirin resistance in secondary stroke prevention
2005
Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma
2003
Coagulation, Fibrinolysis and Platelet P-selectin Expression in Peripheral Vascular Disease
2001
Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A
2006
Plasmatic coagulation and fibrinolytic system alterations in PNH
2003
The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI
2004
The effect of different anticoagulants on thrombin generation
2006
Genetic Predisposition to Bleeding during Oral Anticoagulant Therapy: Evidence for Common Founder Mutations (FIXVal-10 and FIXThr-10) and an Independent CpG Hotspot Mutation (FIXThr-10)
2001
Increased Risk for Postoperative Hemorrhage After Intracranial Surgery in Patients With Decreased Factor XIII Activity
2002
Rankless by CCL
2026